masthead-news

News & Events

HTG Molecular Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

TUCSON, Ariz., Nov. 02, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that its management will be presenting at the Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 17, 2016 in New York City.

full press release

Posted on:

Return To List

Page last updated December 19, 2017